Thus, the observed changes in Myo9A expression and SNO-Myo9A in induced mice with severe DKD could be a direct effect of excess glomerular VEGF-A and not mechanistically contributing to DKD progression. This evidence concerns the gene VEGFA and diabetic kidney disease.